Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: report of the Dutch Cutaneous Lymphoma Group-Reference-Cited by-同舟云学术

Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: report of the Dutch Cutaneous Lymphoma Group

Published:2018-06-21 Issue:3 Volume:179 Page:724-731
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Melchers R.C.¹^ORCID,Willemze R.¹,Bekkenk M.W.²,de Haas E.R.M.³,Horvath B.⁴,van Rossum M.M.⁵,Sanders C.J.G.⁶,Veraart J.C.J.M.⁷,Vermeer M.H.¹,Quint K.D.¹

Affiliation:

1. Department of Dermatology; Leiden University Medical Center; the Netherlands

2. Department of Dermatology; Academic Medical Center and Vrije University Medical Center; Amsterdam the Netherlands

3. Department of Dermatology; Erasmus Medical Center; Rotterdam the Netherlands

4. Department of Dermatology; University Medical Center of Groningen; the Netherlands

5. Department of Dermatology; Radboud University Medical Center; Nijmegen the Netherlands

6. Department of Dermatology; University Medical Center Utrecht; the Netherlands

7. Department of Dermatology; Maastricht University Medical Center; the Netherlands

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.16501/fullpdf

Reference36 articles.

1. WHO-EORTC classification for cutaneous lymphomas;Willemze;Blood.,2005

2. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment;Bekkenk;Blood,2000

3. Outcome of primary cutaneous anaplastic large cell lymphoma: a 20-year British Columbia Cancer Agency experience;Hapgood;Br J Haematol,2016

4. Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome;Woo;Arch Dermatol,2009

5. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma;Kempf;Blood,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD30‐positive lymphoproliferative disorders—An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre;Australasian Journal of Dermatology;2023-03-09

2. Indolente kutane T-Zell-Lymphome;Indolente Lymphome;2023

3. Lymphoproliférations cutanées T CD30+ : Papulose lymphomatoïde et Lymphome cutané anaplasique CD30+;Annales de Dermatologie et de Vénéréologie - FMC;2022-06

4. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management;Journal of the American Academy of Dermatology;2021-11

5. Primary cutaneous anaplastic large‐cell lymphoma: a review of the SEER database from 2005 to 2016;Clinical and Experimental Dermatology;2021-07-17